Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
$ANVS secured non-diluting funds for future trials. Class | jav0033 | investorshub | 04/28/2024 5:20:01 AM |
I'm certainly no expert, but I suspect that | skitahoe | investorshub | 04/28/2024 5:18:06 AM |
Power the Anvs board has the filings. They | tredenwater2 | investorshub | 04/28/2024 4:53:37 AM |
He said MILLIONS of pages for EMA approval | jav0033 | investorshub | 04/28/2024 3:38:01 AM |
Ugly model BTW. | jav0033 | investorshub | 04/28/2024 3:36:14 AM |
When is AGM for this year? Looks like | kund | investorshub | 04/28/2024 2:37:31 AM |
I wondered the same thing earlier. Per the | makemydaze | investorshub | 04/27/2024 11:54:24 PM |
Peace Powerwalker, All is Well. Or | k9uwa | investorshub | 04/27/2024 11:37:45 PM |
That looks like ancient history...delusional WGT keep following | kund | investorshub | 04/27/2024 10:34:41 PM |
From Barron's | georgejjl | investorshub | 04/27/2024 10:24:23 PM |
The definition, from the horse's mouth, could use | FooBarAndGrill | investorshub | 04/27/2024 10:12:17 PM |
FRIENDS, what are rapporteurs in the EMA context?? | meds4life | investorshub | 04/27/2024 10:02:06 PM |
John k9, a lot of people have been | powerwalker | investorshub | 04/27/2024 9:56:00 PM |
I still believe in Anavex science, but the | kund | investorshub | 04/27/2024 7:38:39 PM |
Yes Tom totally agree. Interesting that today was | k9uwa | investorshub | 04/27/2024 6:45:21 PM |
Thanks for the clarification. | Steady_T | investorshub | 04/27/2024 6:26:34 PM |
News is always on the way, and | Investor2014 | investorshub | 04/27/2024 6:14:31 PM |
Got it. That was helpful too, thanks. | frrol | investorshub | 04/27/2024 5:33:15 PM |
plex, Q2 number should be issued by May | powerwalker | investorshub | 04/27/2024 5:12:45 PM |
OK, I was responding to a post about | WilliamMunny | investorshub | 04/27/2024 4:52:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
LOS ANGELES, April 16, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...